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Abstract 
Raynaud's phenomenon (RP) is a clinical sign of precocious abnormal microcirculation and can be 
considered a major risk factor for the development of connective tissue disease, especially systemic 
sclerosis (SSc). Nailfold videocapillaroscopy is the most valuable tool for the early diagnosis of SSc 
and related disorders. It allows classification of capillary abnormalities. Scoring capillaroscopic 
alterations, which change significantly during patient follow-up, should be systematically used in 
order to monitor microangiopathy. The effectiveness of the nailfold videocapillaroscopy in allowing 
an early diagnosis of SSc and monitoring the progression of the disease, and its predictive value of 
clinical complications make it a powerful tool for clinical evaluation and research. 
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1. Introduction 
Although the structural vascular disease in scleroderma is patent, the nature of endothelial injury is 
still elusive, yet markers of endothelial activation and injury continue to be proposed. However, the 
assessment of microvascular function by laboratory methods is not specific or sensitive [1]. 
 
Despite a large prevalence in the general population [2], Raynaud's phenomenon remains a typical 
manifestation of vascular involvement in scleroderma. It is characterized by intense vasospasm of 
the digital arteries under cold exposure or emotional stress, which leads to characteristic color 
changes in the skin of the fingers, which is the expression of the imbalance between vasoconstrictor 
and vasodilator factors [3]. It may be primary or secondary to an underlying condition, especially 
immune-mediated diseases [4]. Physical examination, nailfold capillaroscopy and immunological 
tests can distinguish primary from secondary forms. 
 
Capillaroscopy is an imaging technique, which is used in medicine since 1823, when Purkinje 
described skin capillaries by observing the nail-bed with a magnifying glass. One century later 
(1911), it was discovered that, using a drop of immersion oil, capillaries became visible for 
examination by microscope. More recently, Maricq and Le Roy described the specific 
capillaroscopic pattern in systemic sclerosis. 
 
Nowadays, thanks to its greater magnification (from 50 × to 1000 ×), the digital 
videocapillaroscopy, which consists of a microscope assembled with a digital videocamera, 
represents the gold standard for assessing or measuring capillaroscopic parameters. Furthermore, 
nailfold capillaroscopy is a non-invasive, inexpensive, easy to repeat imaging technique, which is of 
considerable importance for the evaluation of microcirculation in vivo [5]. 
 
2. Capillaroscopic technique 
In order to evaluate capillaries a drop of cedar oil has to be placed on the finger nailfold. A precise 
morphologic evaluation may be obtained by examining the fourth and the fifth finger of both hands 
due to the high transparency of the skin in these areas [5] and [6]. However, all fingers from second 
to fifth should be examined, since early capillary alterations may be on occasionally present in only 
a few digits. Each patient should stay inside the examination room, at a temperature of 23–25 °C, 
for 10–15 min before the nailfold is examined. 
 
The images are generated by lens providing a magnification × 200, and a charged-coupled device 
(CCD) camera giving high-resolution images (752 × 582 pixels). Only the capillaries in the distal 
row are observed. A 1 mm grid is used to quantify capillary density and width. Usually 4 fingers on 
each hand are examined, and at least 8 photo-micrographs are taken of each patient [7]. 
 
The following parameters are routinely evaluated: capillary distribution and width, presence of 
dilated and giant capillaries, loss of capillaries, presence of hemorrhages and signs of 
neoangiogenesis (meandering and ramified capillaries) [8], [9], [10], [11], [12], [13], [14], [15] and 
[16]. Generally speaking, a capillaroscopic feature is considered an abnormal finding if changes are 
observed in at least two fingers [5] and [6]. 
 
3. Clinical implications 
Capillaroscopy is of crucial importance for the differentiation of primary and secondary RP in 
rheumatic diseases, and also in differentiation between different forms of connective tissue diseases 
as well as for their early diagnosis [17]. 
 
The detection of abnormal capillaroscopic patterns has high positive predictive value for the 
development of systemic rheumatic disease [18]. 
 
The most specific pattern is the so called “scleroderma pattern”, which is characterized by the 
presence of giant capillaries, hemorrhages, avascular areas and neoangiogenesis. It is found in more 
than 90% of patients with overt SSc. Similar changes, called “scleroderma-like patterns”, are found 
in patients with dermatomyositis, mixed connective tissue disease, undifferentiated connective 
tissue disease and overlap syndromes [6], [9], [10] and [16]. Absence of abnormal capillaroscopic 
findings can be regarded as a diagnostic criterion for primary RP. 
 
3.1. Normal pattern 
 
In normal conditions, the microvascular pattern is characterized by a regular array of microvessels 
with large intra/interindividual variability [19]. Usually, capillaries show a perpendicular 
disposition to the nailfold edge, with a capillary diameter lower than 20 μm, and at least 9 
capillaries per linear millimeter are present. 
 
3.2. Primary RP 
 
The suggested criteria for primary RP include symmetric attacks, absence of tissue necrosis or 
ulceration or gangrene, absence of a secondary cause, negative tests for antinuclear antibodies and 
normal erythrocyte sedimentation rate. Nailfold capillaries are usually normal-shaped and no 
specific alterations are present [20]. 
 
A diagnosis of primary RP means that no underlying disease has yet been identified, but it is 
difficult to predict if and when it may become secondary RP [21], [22], [23] and [24]. Therefore, a 
follow-up nailfold capillaroscopic analysis is recommended to be performed every 6 months [9] and 
[10]. 
 
Women are 4–20 times more likely than men to develop primary RP. A presentation with 
symmetrical vasospastic attacks and a benign course without skin lesions is typical [25] and [26]. 
The onset of the disease is usually at puberty and is more frequent in certain families [5]. 
 
3.3. Secondary RP 
 
Secondary RP includes a wide spectrum of diseases ranging from peripheral artery disorders and 
connective tissue diseases (CTDs) to paraneoplastic syndromes [27] and [28]. Onset age, which is 
older than primary PR, clinical signs of autoimmune disease, trophic alterations of the fingers [29] 
and [30], positive autoantibodies [5] and abnormal capillaroscopic findings are suggestive features 
of secondary RP. 
 
As calculated by meta-analysis, a secondary disorder develops in 12.6% of patients with presumed 
primary RP. Other studies reported that 15–20% of patients initially diagnosed as affected by 
primary RP transitioned to secondary RP over a mean follow-up of 2 years [31] and [32]. 
 
Notably, RP is the first manifestation in about 90% of patients with SSc [24], [33], [34], [35] and 
[36]. 
 
The microvascular damage in SSc [37] is mainly characterized by increasing structural alterations 
of the capillaries with progressive decrease in their density [38]. Blood flow is also altered, with an 
average slowing of flow and increased periods of stasis [19]. Nagy et al. found specific 
abnormalities in 87.5% of patients with diffuse and in 61.6% with limited form of SSc [5] by 
evaluating advanced capillary changes. Conversely, by assessing both early and advanced capillary 
changes by videocapillaroscopy, more than 98% of SSc patients showed a scleroderma pattern of 
microangiopathy (early, active or late) [39]. 
 
Several studies have graded the morphological aspects of the vascular damage in patients with SSc, 
as assessed by nailfold capillaroscopy [19]. Maricq et al. [15] described two types of capillaroscopic 
changes in SSc. Extensive, confluent avascular areas and neovascularization with a variable 
capillaroscopic pattern have been thought to reflect activity and progression of disease (so called 
“active” capillaroscopic pattern). In contrast, the presence of giant capillary loops with minimal loss 
of capillaries was regarded as typical for the forms of the disease with a lower activity (so called 
“slow” capillaroscopic pattern) [5], [15] and [40]. These patterns are thought to represent two 
different stages of nailfold microangiopathy, even if the factors conditioning timing of transition are 
not known. 
 
In a more recent study, microvascular alterations as detected in SSc by nailfold videocapillaroscopy 
have been re-classified in three pattern, namely “early”, “active” and “late” [41]. 
 
The “early” pattern refers to the presence of a few giant capillaries and hemorrhages along with 
normal-shaped capillaries and relatively well-preserved capillary distribution, without loss of 
capillaries (Fig. 1). The “active” pattern is mainly characterized by the detection of several giant 
capillaries along with mild loss of capillaries [19] (Fig. 2). The “late” pattern is characterized by 
loss of capillaries with extensive avascular areas, ramified capillaries and disorganization of the 
vascular array [5] (Fig. 3). 
In order to quantify the microvascular changes, a semiquantitative rating scale was recently adopted 
to score each capillary abnormality (0, no changes; 1, < 33% of capillary alterations/reduction; 2, 
33–66% of capillary alterations/reductions; and 3, > 66% of capillary alteration/reduction per linear 
millimeter) [42]. The mean score for each capillaroscopic parameter was calculated on four 
consecutive fields (each of 1 linear millimeter) in the middle of the nailfold in each digit and the 
average score from the eight digits, added together, was divided by eight. The score for each 
capillaroscopic parameter was found to differ in the follow-up, even when a variation in the 
microangiopathy pattern was not obvious. Score for irregularly enlarged capillaries, capillaries loss, 
disorganization of the microvascular array and capillary ramifications were found to have increased, 
while scores for giant capillaries and hemorrhages decreased during follow-up. A 4% variability 
was found in the score assessment by the different evaluators [43], [44] and [45]. 
 
As regard to other CTD patients presenting with secondary RP, since more than 20% of UCTD 
patients have been reported to develop SSc [46], it has been suggested that using 
videocapillaroscopy might identify those patients who are candidates to develop SSc. In SLE, both 
enlarged capillaries [47] and capillary loss [48] may occasionally be present. SLE patients with 
capillary loss may also exhibit scleroderma-related symptoms including interstitial lung disease. 
Patients with MCTD, characterized by the simultaneous presence of symptoms characteristic of 
SLE, myositis and scleroderma, in conjuncton with high titre of anti U1 RNP antibody can also 
present with scleroderma capillary pattern and bushy capillary loops [49]. In Sjogren's syndrome 
the “scleroderma pattern” can be detected especially in patients with RP and anticentromer 
antibodies. A number of morphological abnormalities have been also observed in mixed 
cryoglobulinemia. These alterations were reported to be often clustered in a characteristic pattern of 
abnormally oriented and short capillaries with neoangiogenetic phenomena, and were more 
frequently detected in patients with glomerular involvement [19] and [50]. 
 
Of note, in CTD patients, RP has been proposed to be the expression of a systemic disorder in 
which spasms were not restricted to peripheral arteries, but also involved the coronary vessels, 
arterioles of lung, brain, retina and gastrointestinal tract [5]. 
 
4. Concluding remarks 
SSC is a rare multisystemic connective tissue disease characterized by microvascular damage [51], 
fibrosis of the skin [29] and internal organs [52], [53], [54] and [55], and specific immunologic 
abnormalities [56]. The clinical recognizable disease is classified on the basis of extent of skin and 
internal organ involvement [53]. The clinical expression and the course of the disease may be 
associated with severe morbidity and mortality. Moreover, to date, none of the treatments tested in 
randomized controlled trials have been able to halt the natural progression of the disease. Nail fold 
videocapillaroscopy is the most valuable tool for the early diagnosis of SSc and related disorders 
[57]. Scoring the capillaroscopic patterns, which changes significantly during the follow-up of these 
patients, should be systematically employed in order to quantify microangiopathy [44]. 
 
Take-home messages 
• The Raynaud's phenomenon is a clinical sign of precocious abnormal microcirculation and can be 
considered a risk factor for the development of connective tissue disease, especially SSc. 
• The nail fold videocapillaroscopy can be used for the early detection of microvascular 
abnormalities that characterize the secondary RP, and these abnormalities are quantifiable. 
• The effectiveness of the nail fold videocapillaroscopy in the early diagnosis of SSc, its predictive 
value of clinical complications and its potential in monitoring the progression of the disease make it 
a critical non-invasive tool for clinicians and researchers. 
 
References 
[1] M.B. Kahaleh Raynaud's phenomenon and vascular disease in scleroderma Curr Opin 
Rheumatol, 6 (6) (Nov 1994), pp. 621–627 
 
 [2] H.R. Maricq, M.C. Weinrich, J.E. Keil, E.A. Smith, F.E. Harper, A.I. Nussbaum, et al. 
Prevalence of scleroderma spectrum disorders in the general population of South Carolina Arthritis 
Rheum, 32 (1989), pp. 998–1006 
 
 [3] P. Cipriani, A. Marrelli, V. Liakouli, P. Di Benedetto, R. Giacomelli Cellular players in 
angiogenesis during the course of systemic sclerosis Autoimmun Rev, 10 (10) (Aug 2011), pp. 641–
646 
 
 [4] C. Defendenti, F. Atzeni, M.F. Spina, S. Grosso, A. Cereda, G. Guercilena, et al. Clinical and 
laboratory aspects of Ro/SSA-52 autoantibodies Autoimmun Rev, 10 (3) (Jan 2011), pp. 150–154 
 
  
 
[5] Sevdalina Nikolova Lambova, Ulf Müller-Ladner. The role of capillaroscopy in differentiation 
of primary and secondary Raynaud's phenomenon in rheumatic diseases: a review of the literature 
and two case reports Rheumatol Int, 29 (2009), pp. 1263–1271 
 
 [6] R. Bergman, L. Sharony, D. Schapira, M.A. Nahir, A. Balbir-Gurman The handheld 
dermatoscope as a nail-foiled capillaroscopic instrument Arch Dermatol, 139 (2003), pp. 1027–
1030 
 
 [7] P. Formosa Nailfold capillaroscopy techniques J Rheumatol, 23 (2009), pp. 37–429 
 
 [8] H.R. Maricq, E.C. LeRoy, W.A. D'Angelo, T.A. Medsger Jr., G.P. Rodnan, G.C. Sharp, et al. 
Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders Arthritis 
Rheum, 23 (2) (1980), pp. 183–189 
 
 [9] M. Cutolo, W. Grassi, M. Matucci Cerinic Raynaud's phenomenon and the role of 
capillaroscopy Arthritis Rheum, 48 (11) (2003), pp. 3023–3030 
 
 [10] M. Cutolo, C. Pizzorni, A. Sulli Capillaroscopy Best Pract Res Clin Rheumatol, 19 (3) (2005), 
pp. 437–452 
 
 [11] M. Cutolo, A. Sulli, M.E. Secchi, M. Olivieri, C. Pizzorni The contribution of capillaroscopy 
to the differential diagnosis of connective autoimmune diseases. Best Pract Res Clin Rheumatol, 21 
(6) (2007), pp. 1093–1108 
 
 [12] Y. Kabasakal, D.M. Elvins, E.F. Ring, N.J. McHugh. Quantitative nailfold capillaroscopy 
findings in a population with connective tissue disease and in normal healthy controls 
Ann Rheum Dis, 55 (1996), pp. 507–512 
 
 [13] P. Lee, F.Y. Leung, C. Alderdice, S.K. Armstrong.Nailfold capillary microscopy in the 
connective tissue diseases: a semiquantitative assessment J Rheumatol, 10 (6) (1983), pp. 930–938 
 
 [14] F. LeVord, J.C.W. Edwards Nailfold capillary microscopy in connective tissue disease: a 
quantitative morphological analysis Ann Rheum Dis, 45 (1986), pp. 741–749 
 
[15] H.R. Maricq, F.E. Harper, M.M. Khan, E.M. Tan, E.C. LeRoy 
Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and 
early connective tissue disease Clin Exp Rheumatol, 1 (3) (1983), pp. 195–205 
 
 [16] H.R. Maricq. Comparison of quantitative and semiquantitative estimates of nailfold capillary 
abnormalities in scleroderma spectrum disorders 
Microvasc Res, 32 (2) (1986), pp. 271–276 
 
 [17] M. Cutolo, C. Pizzorni, M. Meroni, G. Zampogna, C. Ferrone, E. Alessandri, et al. The role of 
nailfold videocapillaroscopy in Raynaud's phenomenon monitoring and early diagnosis of systemic 
sclerosis Reumatismo, 62 (4) (2010), pp. 237–247 
 
 [18] G. Gitzeimann. Predictive value of nailfold capillaroscopy in patients with Raynaud 
phenomenon. Clin Rheumatol, 25 (2006), pp. 153–158 
 
 
 
[19] M. Cutolo, A. Sulli, M.E. Secchi, S. Paolino, C. Pizzorni. Nailfold capillaroscopy is useful for 
the diagnosis and follow-up of autoimmune rheumatic disease. A future tool for the analysis of 
microvascular heart involvement? Rheumatology, 45 (2006), pp. iv43–iv46 
 
 [20] M. Cutolo, C. Pizzorni, A. Sulli Nailfold video-capillaroscopy in systemic sclerosis 
Rheumatology, 63 (2004), pp. 457–462 
 
 [21] M. Luggen, L. Belhorn, T. Evans, O. Fitzgerald, G. Spencer-Green The evolution of 
Raynaud's phenomenon: a longterm prospective study J Rheumatol, 22 (1995), pp. 2226–2232 
 
 [22] A.L. Herrick The pathogenesis, diagnosis and treatment of Raynaud phenomenon Nat Rev 
Rheumatol, 8 (8) (Aug 2012), pp. 469–479 
 
 [23] O. Fitzgerald, E.V. Hess, G.T. O'Connor, G. Spencer-Green Prospective study of the evolution 
of Raynaud's phenomenon Am J Med, 84 (1988), pp. 718–726 
 
 [24] F. Ingegnoli, P. Boracchi, R. Gualtierotti, C. Lubatti Prognostic model based on nailfold 
capillaroscopy for identifyind Raynaud's phenomenon patients at hig risk for the development of a 
sclerodrerma spectrum disorder PRINCE (prognostic index for nailfold capillaroscopic 
examination) Arthritis Rheum, 58 (7) (July 2008), pp. 2174–2182 
 
 [25] M. Ho, J.J.F. Belch Raynaud's phenomenon: state of the art Scand J Rheumatol, 27 (1998), pp. 
319–322 
 
 [26] A.O. Steven Raynaud's phenomenon J.B. Sterling (Ed.), Secrets of rheumatology, Binom, 
Moscow (2001), pp. 614–619 
 
[27] E. Szekanecz, S. Szamosi, A. Horváth, A. Németh, B. Juhász, J. Szántó, et al. Malignancies 
associated with systemic sclerosis Autoimmun Rev, 11 (12) (Oct 2012), pp. 852–855 
 
 [28] V. Racanelli, M. Prete, C. Minoia, E. Favoino, F. Perosa Rheumatic disorders as 
paraneoplastic syndromes Autoimmun Rev, 7 (5) (May 2008), pp. 352–358 
 
 [29] F. Galluccio, M. Matucci-Cerinic Two faces of the same coin: Raynaud phenomenon and 
digital ulcers in systemic sclerosis Autoimmun Rev, 10 (5) (Mar 2011), pp. 241–243 
 
[30] L. Chung, D. Fiorentino Digital ulcers in patients with systemic sclerosis Autoimmun Rev, 5 
(2) (Feb 2006), pp. 125–128 
 [31]M. Hirschl, K. Hirschl, M. Lenz, R. Katzenschlager, H.P. Hutter, M. Kundi 
Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by 
diagnosis of an associated disease: results of ten years of prospective surveillance Arthritis Rheum, 
54 (6) (2006), pp. 1974–1981 
 
[32]M. Cutolo, C. Pizzorni, A. Sulli Identification of transition from primary Raynaud's 
phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on 
the article by Hirschl et al Arthritis Rheum, 56 (6) (2007), pp. 2102–2103 
 
 [33] G. Spencer-Green Outcomes in primary Raynaud phenomenon: a meta-analysis of the 
frequency, rates, and predictors of transition to secondary diseases 
Arch Intern Med, 158 (1998), pp. 595–600 
 
 [34] M. Hudson, M.J. Fritzler, M. Baron Systemic sclerosis: establishing diagnostic criteria 
Medicine (Baltimore), 89 (3) (May 2010), pp. 159–165 
 
[35] C.G. Kallenberg Early detection of connective tissue disease in patients with Raynaud's 
phenomenon Rheum Dis Clin North Am, 16 (1990), pp. 11–30 
 
[36] H.R. Maricq, P.H. Carpentier, M.C. Weinrich, J.E. Keil, Y. Palesch, C. Biro, et al. 
Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison 
J Rheumatol, 24 (1997), pp. 879–889 
 
[37] C. Chighizola, Y. Shoenfeld, P.L. Meroni Systemic sclerosis. Introduction Autoimmun Rev, 10 
(5) (Mar 2011), pp. 239–240 
 
[38] P.H. Carpentier, H.R. Maricq Microvasculature in systemic sclerosis Rheum Dis Clin North 
Am, 16 (1990), pp. 75–91 
 
[39] M. Cutolo, A. Sulli, V. Smith Assessing microvascular changes in systemic sclerosis diagnosis 
and management Nat Rev Rheumatol, 6 (2010), pp. 578–587 
 
[40] M. Colaci, D. Giuggioli, M. Sebastiani, A. Manfredi, C. Vacchi, P. Spagnolo, et al. 
Lung cancer in scleroderma: results from an Italian Rheumatologic Centre and review of the 
literature Autoimmun Rev (Jun 25 2012) 
 
[41] M. Cutolo, C. Pizzorni, M. Tuccio, A. Burroni, C. Craviotto, M. Basso, et al. Nailfold 
capillaroscopy patters and serum autoantibodies in systemic sclerosis Rheumatology, 43 (2004), pp. 
719–726 
 
[42] A. Sulli, M.E. Secchi, C. Pizzorni, M. Tutolo Scoring the nailfold microvascular changes 
during the capillaroscopic analysis in systemic sclerosis patients Ann Rheum Dis, 67 (6) (Jun 
2008), pp. 885–887 
 
[43] M. Cutolo, C. Pizzorni, M.E. Secchi, A. Sulli Capillaroscopy Best Pract Res Clin Rheumatol, 
22 (6) (2008), pp. 1093–1108 
 
[44] A. Sulli, M.E. Secchi, C. Pizzorni, M. Tutolo Scoring the nailfold microvascular changed 
during the capillaroscopic analysis in systemic sclerosis patients Ann Rheum Dis, 67 (2008), pp. 
885–887 
 [45] A. Sulli, C. Pizzorni, V. Smith, G. Zampogna, F. Ravera, M. Tutolo Timing of transition 
between capillaroscopic patterns in systemic sclerosis Arthritis Rheum, 64 (2012), pp. 821–825 
 
[46] P. Priollet, M. Vayssairat, E. Housset How to classify Raynaud's phenomenon. Long-term 
follow-up study of 73 cases Am J Med, 83 (3) (1987), pp. 494–498 
 
[47] V. Riccieri, A. Spadaro, F. Ceccarelli, R. Scrivo, V. Germano, G. Valesini 
Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity 
and autoantibody profile Lupus, 14 (7) (2005), pp. 521–525 
 
 
 
[48] M. Pallis, N. Hopkinson, R. Powell Nailfold capillary density as a possible indicator of 
pulmonary capillary loss in systemic lupus erythematosus but not in mixed connective tissue 
disease Rheumatology, 18 (10) (1991), pp. 1532–1536 
 
[49] F. Granier, M. Vayssairat, P. Priollet, E. Housset Nailfold capillary microscopy in mixed 
connective tissue disease. Comparison with systemic sclerosis and systemic lupus erythematosus 
Arthritis Rheum, 29 (2) (1986), pp. 189–195 
 
[50]D. Rossi, M. Mansouri, S. Baldovino, C. Naretto, M. Alpa, L.M. Sena, et al. Nail fold 
videocapillaroscopy in mixed cryoglobulinemia Nephrol Dial Transplant, 19 (2004), pp. 2245–2249 
 
[51] S. Guiducci, R. Giacomelli, M.M. Cerinic Vascular complications of scleroderma. Autoimmun 
Rev, 6 (8) (Sep 2007), pp. 520–523 
 
[52] G. Bussone, L. Mouthon Interstitial lung disease in systemic sclerosis Autoimmun Rev, 10 (5) 
(Mar 2011), pp. 248–255 
 
[53] I. Almeida, R. Faria, P. Vita, C. Vasconcelos Systemic sclerosis refractory disease: from the 
skin to the heart Autoimmun Rev, 10 (11) (Sep 2011), pp. 693–701 
 
[54] K.P. Tiev, J. Cabane Digestive tract involvement in systemic sclerosis Autoimmun Rev, 11 (1) 
(Nov 2011), pp. 68–73 [Epub 2010 Jun 22] 
 
[55] S. Lambova, U. Müller-Ladner Pulmonary arterial hypertension in systemic sclerosis 
Autoimmun Rev, 9 (11) (Sep 2010), pp. 761–770 
 
[56] P. Dieudé, C. Boileau, Y. Allanore Immunogenetics of systemic sclerosis Autoimmun Rev, 10 
(5) (Mar 2011), pp. 282–290 
 
[57] W. Grassi, P. Del Medico, F. Izzo, C. Cervini Microvascular Involvement in systemic 
sclerosis: capillaroscopic findings Semin Arthritis Rheum, 30 (6) (June 2001), pp. 397–402 
 
 
Fig. 1.  A. Normal nailfold capillaroscopic pattern showing regular disposition of the capillary loops 
along the nail bed. B. Scleroderma pattern early. The arrow indicates a single giant capillary. 
 
 
 
 
 
Fig. 2. Scleroderma pattern active. Typical giant capillary of the nailfold. 
 
 
 
 
Fig. 3.  Scleroderma pattern late. Capillary loss, fibrosis and intensive angiogenesis. 
 
